Bristol diabetes drug yields improvements in study

Status
Not open for further replies.

Northerner

Admin (Retired)
Relationship to Diabetes
Type 1
Bristol said the treatment, dapagliflozin, fared better than a placebo, or fake drug, in a late-stage study of patients with type 2 diabetes who were taking a combination of metformin plus sulfonylurea.

Patients taking the drug also saw blood pressure improvements after eight weeks compared to those taking a placebo.

Dapagliflozin, a once-a-day pill, was approved in the European Union last November, where it is known as Forxiga. The drug works independently of insulin to remove excess blood sugar from the body differently than other type 2 diabetes drugs.

http://www.businessweek.com/ap/2013-09-24/bristol-diabetes-drug-yields-improvements-in-study
 
Status
Not open for further replies.
Back
Top